β-endorphin and natural killer cell cytolytic activity during prolonged exercise. Is there a connection?

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 275, Issue 6 44-6, 1998, Pages

  Gannon, G A ^a   Rhind, S G ^b   Suzui, M ^c,d   Zamecnik, J ^e   Sabiston, B H ^f   Shek, P N ^d   Shephard, R J ^d  

^a Graduate Programme in Exercise Sciences   (Japan)

^b Faculty of Physical Education   (Japan)

^c UNIVERSITY OF TORONTO   (Canada)

^d DEF AND CIV INST OF ENVIRON MED   (Canada)

^e BROCK UNIVERSITY   (Canada)

^f MEIJI UNIVERSITY   (Japan)

Author keywords

Cell adhesion; Cortisol; Growth hormone; Naltrexone; Natural immunity

Indexed keywords

BETA ENDORPHIN; GROWTH HORMONE; HYDROCORTISONE; NALTREXONE;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CELL ADHESION; CELL COUNT; CELL INTERACTION; CYTOLYSIS; EFFECTOR CELL; EXERCISE; HUMAN; HUMAN EXPERIMENT; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NERVE BLOCK; NORMAL HUMAN; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TARGET CELL;

EID: 0032415567     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.275.6.r1725     Document Type: Article

References (56)

1. Akil, H., E. Young, S. J. Watson, and D. H. Coy. Opioid binding properties of naturally occurring N- and C-terminus β-endorphins. Peptides 2:289-292, 1981.
2. Aronin, N., M. Wiesen, A. S. Liotta, G. C. Schussler, and D. T. Krieger. Comparative metabolic clearance rates of beta-endorphin and beta-lipotropin in humans. Life Sei. 29: 1265-1269,1981.
3. Brammert, M., and B. Hokfelt. The influence of naloxone on exercise-induced increase in plasma pituitary hormones and the subjectively experienced level of exhaustion in healthy males. Acta Endocrinol. 115:125-130,1987.
4. Brenner, L, Y. D. Severs, P. N. Shek, and R. J. Shephard. Impact of heat exposure and moderate, intermittent exercise on cytolytic cells. Eur. J. Appl. Physiol, 74:162-171,1996.
5. Carr, D. J., B. R. DeCosta, C.-H. Kim, A. E. Jacobson, K. L. Best, K. C. Rice, and J. E. Blalock. Anti-opioid receptor antibody recognition of a binding site on brain and leukocyte opioid receptors. Neuroendocrinology 51:552-560,1990.
6. Chiappelli, K, N. Yamashita, M. Faisal, M. Kemeny, R. Bullington, L. Nguyen, L. T. Clement, and J. L. Fahey. Differential effect of beta-endorphin on three human cytotoxic cell populations. Int. J. Immunopharmacol. 13:291-297,1991.
7. Grist, D. M., and J. C. Kraner. Supplemental growth hormone increases the tumor cytotoxic activity of natural killer cells in healthy adults with normal growth hormone secretion. Metabolism 39:1320-1324,1990.
8. DeRijk, R. H., J. Petrides, P. Deuster, P. W. Gold, and E. M. Sternberg. Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans. J. Clin. Endocrinol. Metab. 81:228-235,1996.
9. Dill, D., and D. Costill. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J. Appl. Physiol. 37: 247-248,1974.
10. Farrell, P., A. Gustafson, T. Garthwaite, R. Kalkhoff, A. J. Cowley, and W. Morgan. Influence of endogenous opioids on the response of selected hormones to exercise in humans. J. Appl. Physiol. 61:1051-1057,1986.
11. Fiatarone, M., J. Morley, E. Bloom, D. Benton, T. Makinodan, and G. Solomon. Endogenous opioids and the exerciseinduced augmentation of natural killer cell activity. J. Lab. Clin. Med. 112:544-552,1988.
12. Froelich, C., and A. Bankhurst. The effect of β-endorphin on natural cytotoxicity and antibody dependent cellular cytotoxicity. Life Sci. 35:261-265,1984.
13. Gannon, G. A., S. G. Rhind, M. Suzui, P. N. Shek, and R. J. Shephard. Circulating levels of peripheral blood leucocytes and cytokines following competitive cycling. Can. J. Appl. Physiol. 22:133-147,1997.
14. Gannon, G. A., P. N. Shek, and R. J. Shephard. Natural killer cells: modulation by intensity and duration of exercise. Exerc. Immunol. Rev. 1:26-48,1995.
15. Gatti, G., R. Cavallo, M. L. Sartori, D. Del Ponte, R. Masera, A. Salvadori, R. Carignola, and A. Angeli. Inhibition by cortisol of human natural killer (NK) cell activity. J. Steroid Biochem. 26:49-58,1987.
16. 2 are additive inhibitors of human natural killer cell activity. Immunopharmacology 11:119-128,1986.
17. Gatti, G., R. G. Masera, L. Pallavicini, M. L. Sartori, A. Staurenghi, F. Orlandi, and A. Angeli. Interplay in vitro between ACTH, β-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity. Brain Behav. Immun. 7:16-28,1993.
18. Goldfarb, A., B. Hatfield, D. Armstrong, and J. Potts. Plasma beta-endorphin concentration: response to intensity and duration of exercise. Med. Sei. Sports Exerc. 22:241-244,1990.
19. Goldfarb, A. H., and A. Z. Jamurtas. β-Endorphin response to exercise: an update. Sports Med. 24:8-16,1997.
20. Grossman, A., P. Bouloux, P. Price, P. L. Drury, K. S. L. Lam, T. Turner, J. Thomas, G. M. Besser, and J. Sutton. The role of opioid peptides in the hormonal responses to acute exercise in man. Clin. Sei. (Colch.) 67:483-491,1984.
21. Guillemin, R., T. Vargo, J. Rossier, S. Minick, N. Ling, C. Rivier, W. Vale, and F. Bloom. β-Endorphin and adrenocorticotropin are secreted concqmitantly by the pituitary gland. Science 197:1367-1369,1977.
22. Hatam, L., S. Schuval, and V. Bonagura. Flow cytometric analysis of natural killer cell function as a clinical assay. Cytometry 16: 59-68,1994.
23. Hazum, E., K.-J. Chang, and P. Cuatrecasas. Specific nonopiate receptors for β-endorphin. Science 205:1033-1035,1979.
24. Holbrook, N. J., W. I. Cox, and H. C. Horner. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Res. 43:4019-4025,1983.
25. Jonsdottir, I. H., P. Hoffman, and P. Thoren. Physical exercise, endogenous opioids and immune function. Acta Physiol, Scand. 161:47-50,1997.
26. Jonsdottir, I. H., C. Johansson, A. Asea, K. Hellstrand, P. Thoren, and P. Hoffman. Chronic intracerebroventricular administration of β-endorphin augments natural killer cell cytotoxicity in rats. Regul. Pept. 62:113-118,1996.
27. Kappel, M., N. Tvede, H. Galbo, P. Haahr, M. Kjaer, M. Linstow, K. Klarlund, and B. K. Pedersen. Evidence that the effect of physical exercise on NK cell activity is mediated by epinephrine. J. Appl. Physiol. 70:2530-2534,1991.
28. Kay, N., J. Alien, and J. E. Morley. Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci. 35:53-59,1984.
29. Kay, N. E., J. E. Morley, and J. I. Alien. Interaction between endogenous opioids and IL-2 on PHA-stimulated human lymphocytes. Immunology 70:485-491,1990.
30. Klokker, M., M. Kjaer, N. M. Secher, B. Hanel, L. Worm, M. Kappel, and B. K. Pedersen. Natural killer cell response to exercise in humans: effect of hypoxia and epidural anesthesia. J. Appl. Physiol. 78:709-716,1995.
31. Mackinnon, L. T., T. W. Chick, A. van As, and T. B. Tomasi. Effects of prolonged intense exercise on natural killer cell number and function. In: Exercise Physiology: Current Selected Research, edited by C. O. Dotson and J. H. Humphrey. New York: AMS, vol. 3,1998, p. 77-89.
32. Mandler, R. N., W. E. Biddison, R. Mandler, and S. A. Serrate. β-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J. Immunol. 136: 934-939,1986.
33. Martin-Kleiner, I. and J. Gabrilovac. Naloxone modulates NK cell activity of human peripheral blood lymphocytes like an opioid agonist. Immunopharmacol. Immunotoxicol. 15:179-197, 1993.
34. Mathews, P. M., C. J. Froelich, W. L. Sibbitt, and A. D. Bankhurst. Enhancement of natural cytotoxicity by β-endorphin. J. Immunol. 130:1658-1662,1983.
35. Monti, K. M., R. L. Foltz, and D. M. Chinn. Analysis of naltrexone and β-naltrexol in plasma and urine by gas chromatography/negative ion chemical ionization mass spectrometry. J. Anal Toxicol. 15:136-140,1991.
36. Moretti, C., A. Fabbri, L. Gnessi, M. Cappa, A. Calzolari, F. Fraioli, A. Grossman, and G. M. Besser. Naloxone inhibits exercise-induced release of PRL and GH in athletes. Clin. Endocrinol. (Oxf.) 18:135-138,1983.
37. Ortaldo, J. R. Cytotoxicity by natural killer cells: analysis of large granular lymphocytes. Methods Enzymol. 132: 445-457, 1986.
38. Paneri, A. E., and P. Sacerdote. β-Endorphin in the immune system: a role at last? Immunol. Today 19:317-319,1997.
39. Pedersen, B., and H. Ullum. NK cell response to physical activity: possible mechanisms of action. Med. Sei. Sports Exerc. 26:140-146,1994.
40. Pedersen, B. K., and J. M. Beyer. Characterization of the in vitro effects of glucocorticosteroids on NK cell activity. Allergy 41: 220-224,1986.
41. Flaut, M. Lymphocyte hormone receptors. Annu. Rev. Immunol. 5:621-669,1987.
42. Prete, P., E. R. Levin, and A. Pedram. The in vitro effects of endogenous opiates on natural killer cells, antigen-specific cytolytic T cells, and T-cell subsets. Exp. Neural. 92:349-359,1986.
43. 42a.Rhind, S. G., G. A. Cannon, P. N. Shek, and R. J. Shephard. Effects of 2 h of exercise and in vivo indomethacin on circulating PGE2 levels and NK cell activity (Abstract). Med. Sei. Sports Exerc. 30: S20,1998.
44. Rhind, S. G., G. A. Gannon, M. Suzui, P. N. Shek, and R. J. Shephard. Determination of natural killer cell cytolytic activity by flow cytometry: applications in studies of exercise immunology (Abstract). Int. J. Sports Med. 18: S113,1997.
45. Robertson, M., M. Caligiuri, T. Manley, H. Levine, and J. Ritz. Human natural killer cell adhesion molecules: differential expression after activation and participation in cytolysis. J. Immunol. 145: 3194-3201,1990.
46. Robertson, M. J., and J. Ritz. Biology and clinical relevance of human natural killer cells. Blood 76:2421-2438,1990.
47. Schmidt, R. E., G. Hartley, H. Levine, S. F. Schlossman, and J. Ritz. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. J. ImmunoL 135:1020-1025,1985.
48. Schmidt, R. E., J. P. Caulfield, J. Michon, A. Hein, M. M. Kamada, R. P. MacDermott, R. L. Stevens, and J. Ritz. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules. J. Immunol. 140:991-1002,1988.
49. Schwarz, L., and W. Kindermann. Changes in beta-endorphin levels in response to aerobic and anaerobic exercise. Sports Med. 13: 25-36,1992.
50. Shinkai, S., S. Shore, P. N. Shek, and R. J. Shephard. Acute exercise and immune function: relationship between lymphocyte activity and changes in subset counts. Int. J. Sports Med. 13: 452-461,1992.
51. Song, L.-N. Stress-induced changes in glucocorticoid receptors: molecular mechanisms and clinical implications. Mol. Cell. Endocrinol. 80: C171-C174,1991.
52. Spiler, I. J., and M. E. Molitch. Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors. J. Clin.Endocrinol. Metab. 50: 516-520,1980.
53. Targan, S., L. Britvan, and F. Dorey. Activation of human NKCC by moderate exercise: increased frequency of NK cells with enhanced capability of effector-target lytic interactions. Clin. Exp. Immunol. 45:352-360,1981.
54. Timonen, T., C. G. Gahmberg, and M. Patarroyo. Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes. Int. J. Cancer 46:1035-1040,1990.
55. Verebey, K., J. Volavka, S. J. Mule, and R. B. Resnick. Naltrexone: disposition, metabolism, and effects after acute and chronic dosing. Clin. Pharmacol. Ther. 20:315-328,1976.
56. Williamson, S., R. Knight, S. Lightman, and J. Hobbs. Differential effects of β-endorphin fragments on human natural killing. Brain Behav. Immun. 1: 329-335,1987.